<DOC>
	<DOCNO>NCT01335581</DOCNO>
	<brief_summary>The purpose study evaluate RevLite laser treatment refractory mixed type melasma .</brief_summary>
	<brief_title>Study Laser Treatment Melasma</brief_title>
	<detailed_description />
	<mesh_term>Melanosis</mesh_term>
	<criteria>Fitzpatrick Skin Type IIIVI mixed ( epidermal dermal ) melasma diagnose Wood 's Lamp exam age 18 old melasma persist great 6 month fail respond conventional treatment hydroquinone topical lightening agent write verbal informed consent willing able comply study instruction return clinic require visit Pregnancy , breastfeeding , take birth control pill plan become pregnant study history cutaneous photosensitization , porphyria , hypersensitivity porphyrin photodermatosis skin pathology condition could interfere evaluation require use interfere topical systemic therapy uncorrected coagulation defect currently use anticoagulation medication ( include limit heavy aspirin therapy ) condition , investigator 's opinion , would make unsafe subject participate research study currently enrol investigational drug device trial , receive investigational drug treat investigational device within 30 day prior enter study inability communicate cooperate investigator due language problem , poor mental development , impaired cerebral function unreliability study ( include subject engage excessive alcohol intake drug abuse , subject unable return schedule followup visit ) use photosensitize drug within timeframe photosensitization drug may still present need expose artificial tanning device excessive sunlight trial Diabetes Type I II sensitivity hydroquinone RetinA evidence compromise immune system hepatitis use bleach cream retinoids within last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>